279 results on '"Chavin K"'
Search Results
2. (371) Testosterone Levels after Lung Transplant: An Analysis of the TriNetX Research Network
3. (062) Testosterone Therapy Improves Mortality after Solid Organ Transplant
4. Early Aspirin Therapy May Reduce Hepatic Artery Thrombosis in Liver Transplantation
5. Clinical Outcomes and Costs Associated with In-hospital Biliary Complications After Liver Transplantation: a Cross-Sectional Analysis
6. Addressing Diaphragm Dysfunction in Lung Transplant Recipients: The Expanding Role of Diaphragm Pacing
7. Black Race Is Associated with Underutiliztion of Transplantation for T1 Hepatocellular Carcinoma Regardless of Age or Insurance Status
8. Vitamin E Succinate Enhances Steatotic Liver Energy Status and Prevents Oxidative Damage Following Ischemia/Reperfusion
9. Vitamin E Succinate Reduces Ischemia/Reperfusion Injury in Steatotic Livers
10. Use of Propensity Scoring to Discern the Predominant Etiologies Surrounding Racial Disparities in Kidney Transplant.: Abstract# B1195
11. The Clinical and Economic Impact of 30-Day Readmissions in Kidney Transplant.: Abstract# A448
12. Perioperative Albumin vs. HES Products in Orthotopic Liver Transplant.: Abstract# C2001
13. Impact of Pre-Transplant Opiate Use On Outcomes in Liver Transplant Recipients.: Abstract# C1940
14. Resource Utilization of Patients On Opiates Prior to Liver Transplant: The Squeaky Wheel Phenomenon?: Abstract# C1939
15. Renal Benefit With Everolimus (EVR) and Reduced Tacrolimus (TAC) vs Standard TAC Is Maintained to 3 Years After Liver Transplantation in North America (NA).: Abstract# A427
16. Pharmacist Chart Reviews Cannot Replace Direct Care in the Management of Renal Transplant Recipients.: Abstract# D2444
17. Predictability of a Risk Model for Reductions in Immunosuppression After Kidney Transplantation.: Abstract# D2433
18. Differences in BK Viral Clearance Kinetics across Recipient Race.: Abstract# B1013
19. Risk Factors for Development of Opportunistic Infections in Pediatric Renal Transplant Patients.: Abstract# A344
20. Evaluation of Racial Disparities in Pediatric Kidney Transplant.: Abstract# A345
21. The Association Between Pharmacotherapy and Healthcare Value in U.S. Kidney Transplant Programs.: Abstract# A166
22. Knocking Out TLR4 Protects Mice From Non Alcoholic SteatoHepatitis But Not Obesity.: Abstract# A112
23. Bacteria Are Required for Non-Alcoholic Steatohepatits (NASH).: Abstract# A118
24. Early Graft Loss, Cardiovascular Risk Factor Control and African-American Disparities in Kidney Transplantation.: Abstract# 733
25. Factors Influencing Peri-Operative Value in Kidney Transplant.: Abstract# 2887
26. Race Modifies CMV Viral Kinetics and Renal Transplant Outcomes.: Abstract# 2880
27. The Association Between Peri-Operative Quality and Patient Outcomes in Liver Transplant.: Abstract# 2269
28. Depression Management, Resource Utilization and Outcomes Following Liver Transplant.: Abstract# 1497
29. Risk Factors and Associated Outcomes of Medication Non-Adherence in Pediatric Kidney Transplant Recipients.: Abstract# 2937
30. Clinical Outcomes and Cardiometabolic Indices Post Kidney Transplant in Gastric Bypass Patients: A Propensity Score Matching Analysis.: Abstract# 2149
31. Predictability of a 30-Day Readmission Risk Model in Kidney Transplant Recipients.: Abstract# 637
32. Diaphragm Pacing in Lung Transplant Patients: To Identify and Treat Diaphragm Function Abnormalities
33. Critical analysis of valganciclovir dosing and renal function on the development of cytomegalovirus infection in kidney transplantation
34. Everolimus facilitated reduction of tacrolimus in de novo liver transplant recipients (LTxR): 12–24 month data from North America.: 184E.
35. Renal Function at Two Years in Liver Transplant Patients Receiving Everolimus: Results of a Randomized, Multicenter Study
36. Improving Transplant Patient Safety Through Pharmacist Discharge Medication Reconciliation
37. Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial
38. Improving Patient Safety after Solid Organ Transplantation: A Focused Approach To Prevent Medication Errors.: Abstract# 1684: Poster Board #-Session: P246-IV
39. Nothing Wrong with a Little Fat? A Surgical Algorithm to Safely Use Steatotic Livers.: Abstract# 1675: Poster Board #-Session: P237-IV
40. Determining How to Efficiently Utilize Induction Therapy in Kidney Transplant (KTX) Patients Using a Risk to Benefit Ratio.: Abstract# 1509 Poster Board #-Session: P71-IV
41. Critical Analysis of BK Infection in Kidney Transplant Recipients with Modern Immunosuppression.: Abstract# 1089: Poster Board #-Session: P254-II
42. Does RATG Induction Therapy Increase the Risk of Severe Infection in Kidney Transplant Recipients?: Abstract# 992 Poster Board #-Session: P157-II
43. mTOR Inhibitor Attributed Adverse Events: Results from the H2304 Study Comparing Everolimus and Tacrolimus in De Novo Liver Transplant Recipients.: Abstract# 332
44. TLR4 Blocking Peptide Improves Islet Survival and Function.: Abstract# 226
45. Prospective Comparative Efficacy of Induction Therapy in a High-Risk Kidney Transplant (KTX) Population.: Abstract# 104
46. Everolimus with Early Reduction or Elimination of Tacrolimus in 719 De Novo Liver Transplant Recipients — 12 Month Efficacy and Safety Results from H2304 Study.: Abstract# 5
47. A critical analysis of racial difference with mycophenolate mofetil (MMF) dosing, clinical outcomes and adverse effects in pediatric kidney transplant patients
48. HLA-C and Liver Transplant Outcomes: Interpreting the Facts
49. The use of drotrecogin alfa (activated) in solid organ transplant patients: a case series
50. C-Jun N-Terminal Kinase 2 Promotes Graft Injury via the Mitochondrial Permeability Transition After Mouse Liver Transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.